Royal Dutch Shell plc:企業のM&A・事業提携・投資動向

◆英語タイトル:Royal Dutch Shell plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1893
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:113
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:石油・ガス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Royal Dutch Shell plc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Royal Dutch Shell plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Royal Dutch Shell plc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Royal Dutch Shell plc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Royal Dutch Shell plc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Royal Dutch Shell plc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Royal Dutch Shell plc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Royal Dutch Shell plc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Royal Dutch Shell plc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
PARTNERSHIP 20
Partnership – Overview 20
Partnership – Deal reports 21
CAPITAL RAISING 33
Capital Raising – Deal reports 33
DIVESTMENTS 36
Divestments – Overview 36
Divestments – Deal reports 37
APPENDIX 103
Contact Us 103
About MarketLine Financial Deals Database 103
Deal Definition and Methodology 105
About MarketLine 112

List of Tables
Table 1: Royal Dutch Shell plc M&A volume and value trend (2014-YTD2018)
Table 2: Royal Dutch Shell plc M&A activity by geography (2014-YTD2018)
Table 3: Royal Dutch Shell plc partnership volume and value trend (2014-YTD2018)
Table 4: Royal Dutch Shell plc partnership trend by key deal type (2014-YTD2018)
Table 5: Royal Dutch Shell plc divestments volume and value trend (2014-YTD2018)
Table 6: Royal Dutch Shell plc divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Royal Dutch Shell plc M&A volume and value trend (2014-YTD2018)
Figure 2: Royal Dutch Shell plc M&A activity by geography (2014-YTD2018)
Figure 3: Royal Dutch Shell plc partnership volume and value trend (2014-YTD2018)
Figure 4: Royal Dutch Shell plc partnership trend by key deal type (2014-YTD2018)
Figure 5: Royal Dutch Shell plc divestments volume and value trend (2014-YTD2018)
Figure 6: Royal Dutch Shell plc divestments by geography (2014-YTD2018)

★海外企業調査レポート[Royal Dutch Shell plc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Denbury Resources Inc.:企業の戦略・SWOT・財務分析
    Denbury Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Denbury Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Meta Biomed Co Ltd (059210):企業の製品パイプライン分析2018
    Summary Meta Biomed Co Ltd (Meta Biomed) is a medical device company that develops and manufactures dental materials and equipments. The company provides suture, dental, bone and medical products. It offers various medical products such as endodontic materials, bone restorative materials, implant ma …
  • South Egypt Drug Industries Co:企業の戦略的SWOT分析
    South Egypt Drug Industries Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Xtant Medical Holdings Inc (XTNT):医療機器:M&Aディール及び事業提携情報
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowr …
  • Komatsu Ltd (6301):企業の財務・戦略的SWOT分析
    Komatsu Ltd (6301) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • AMETEK Inc (AME):医療機器:M&Aディール及び事業提携情報
    Summary AMETEK Inc (AMETEK) is an electronic products manufacturing company that manufactures electronic instruments and electromechanical devices. The company's products include medical materials, motion control systems, sub assemblies and connectors, electrical cord reels, gauges, titanium alloys …
  • Australian Vanadium Ltd (YRR):企業の財務・戦略的SWOT分析
    Summary Australian Vanadium Ltd (AVL), formerly Yellow Rock Resources Ltd, is a mining company that explores and develops titanium, vanadium, copper, gold, and uranium metals. The company’s projects include Gabanintha Gold Copper Project, The Australian Vanadium Project, Coates Vanadium Project, Now …
  • Panacea Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Panacea Pharmaceuticals Inc (Panacea) is a clinical stage biopharmaceutical company that discovers, develops and commercializes therapeutic and diagnostic products for the treatment of cancer and central nervous system diseases. The company’s pipeline products include PAN-301-1, a human aspa …
  • FirstRand Limited (FSR):企業の財務・戦略的SWOT分析
    FirstRand Limited (FSR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Vericel Corp (VCEL)-製薬・医療分野:企業M&A・提携分析
    Summary Vericel Corp (Vericel) formerly Aastrom Biosciences, Inc. is a medical device company that develops patient-specific expanded cellular therapies to repair and regenerate damaged tissue for the treatment of severe, chronic ischemic cardiovascular diseases. It markets two autologous cell thera …
  • Eone Diagnomics Genome Center Co Ltd (245620):企業の製品パイプライン分析
    Summary Eone Diagnomics Genome Center Co Ltd (EDGC) develops genome analysis technology solutions. The company focuses on the development of clinical genomic products for non-invasive prenatal test; newborn genetic screening test, hereditary cancer prediction test, female cancer prediction test and …
  • Citizens Financial Corp.:企業の戦略・SWOT・財務情報
    Citizens Financial Corp. - Strategy, SWOT and Corporate Finance Report Summary Citizens Financial Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Inchcape plc (INCH):企業の財務・戦略的SWOT分析
    Inchcape plc (INCH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • China International Travel Service Corporation Limited:企業の戦略・SWOT・財務分析
    China International Travel Service Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary China International Travel Service Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company' …
  • Bank of Hawaii Corp (BOH):企業の財務・戦略的SWOT分析
    Bank of Hawaii Corp (BOH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Amcor Ltd:戦略・SWOT・企業財務分析
    Amcor Ltd - Strategy, SWOT and Corporate Finance Report Summary Amcor Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Metanomics Health GmbH:企業の製品パイプライン分析2018
    Summary Metanomics Health GmbH (Metanomics), a subsidiary of BASF SE, is a biotech company that provides metabolic biomarker identification and validation solutions. The company offers analysis of metabolites for various applications in pharma and biotech, biobanking, academia, food and feed industr …
  • LeasePlan Corporation N.V.:戦略・SWOT・企業財務分析
    LeasePlan Corporation N.V. - Strategy, SWOT and Corporate Finance Report Summary LeasePlan Corporation N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Merz Pharma GmbH & Co. KGaA:企業のM&A・事業提携・投資動向
    Merz Pharma GmbH & Co. KGaA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Merz Pharma GmbH & Co. KGaA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Cypress Energy Partners LP (CELP):石油・ガス:M&Aディール及び事業提携情報
    Summary Cypress Energy Partners LP (Cypress Energy), a subsidiary of Cypress Energy Holdings LLC, is an energy services company that provides midstream services. The company provides services such as pipeline inspection, integrity and hydrostatic testing services to energy, exploration and productio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆